Welcome to our dedicated page for Neutra news (Ticker: NTRR), a resource for investors and traders seeking the latest updates and insights on Neutra stock.
Neutra Corp (NTRR) is a Texas-based innovator in hemp-derived wellness products, including CBD tinctures and clinical-grade topicals. This news hub provides investors and industry observers with essential updates on the company's strategic initiatives and market expansion.
Discover official announcements ranging from product innovations to financial developments, all supporting Neutra Corp's mission to lead in natural wellness solutions. The curated collection includes updates on manufacturing advancements, regulatory compliance progress, and partnership developments within the specialty healthcare sector.
Key focus areas mirror the company priorities outlined in its two-year management plan: direct-to-consumer platform growth, clinical research investments, and educational consulting services expansion. Users will find timely updates on operational milestones including production capacity increases and distribution network enhancements.
Bookmark this page for streamlined access to Neutra Corp's evolving position in the competitive wellness market. Verify time-sensitive details through official SEC filings and corporate communications linked where available.
Neutra Corp. (OTC PINK:NTRR) reported record sales in March 2021, marking its best month ever. The company is advancing plans to place its VIVIS-brand CBD products in two major big-box retail chains, as demand increases following the easing of COVID-19 restrictions. Neutra's national sales team, established in January, has played a vital role in this growth. With over 100 million COVID vaccinations administered, the company anticipates further sales boosts as the economy reopens. VIVIS products stand out due to their lab-tested purity and potency, appealing to health-conscious consumers.
Neutra Corp. (OTC PINK:NTRR) announced that its subsidiary VIVIS is completing vendor forms to sell its hemp-based CBD products at two major retailers in the Midwest and Mid-Atlantic regions. This initiative follows a reported increase in foot traffic as COVID-19 vaccine distribution accelerates. CEO Sydney Jim highlighted that their production capabilities are in place, and VIVIS is well-regarded among CBD consumers due to its lab-tested products. As states reopen economies, Neutra anticipates expanded market opportunities for its products.
Neutra Corp. (NTRR) anticipates a boost in marketing and sales as COVID-19 restrictions ease in Texas and other states. Following the end of the statewide mask mandate, Neutra's CEO, Sydney Jim, expressed optimism about in-person interactions with retailers, which are crucial for building relationships and product sampling. The company's subsidiary, VIVIS, is enhancing its production capabilities and exploring entry into the cannabis-based CBD market as regulations relax. These trends may positively affect Neutra's sales moving forward.
Neutra Corp. (NTRR) is exploring entry into the medical and recreational cannabis markets as state regulations relax, particularly following New Jersey's recent legalization of recreational use for adults. With 15 states now fully legalizing cannabis, the potential market for CBD products is expanding.
Neutra's management possesses extensive experience in various cannabis sectors, offering a strong foundation for this strategic move. The company aims to leverage these changes amidst shifting public attitudes towards cannabis, indicating a promising market outlook.
Neutra Corp. (NTRR) announces a significant expansion of its wholly owned subsidiary, VIVIS, in Katy, TX. This expansion enhances VIVIS's in-house testing lab capabilities, improving the testing of hemp-based products for quality and potency. Neutra emphasizes that this development supports the streamlined manufacturing process and prepares the company for increased demand for its CBD products. Additionally, Neutra's national sales team has seen positive responses from major retail outlets, indicating strong market interest despite ongoing pandemic challenges.
Neutra Corporation (NTRR) has launched a new website for its subsidiary, VIVIS CBD, marking a significant update after a year. CEO Sydney Jim expressed excitement over the redesign, which includes affordable pricing and free shipping for February. VIVIS plans to introduce a new product line and expand its retail presence nationwide, with potential developments in Texas. Demand for hemp-based CBD products remains strong despite the COVID-19 pandemic, with a Brightfield report indicating a 40% increase in usage among consumers.
Neutra Corp. (OTC PINK:NTRR) announced no plans for a share consolidation, choosing instead to focus on expanding its wholly owned subsidiary, VIVIS CBD. CEO Sydney Jim highlighted recent achievements, including a new production facility, product launches, and a national sales team. The company aims for complete vertical integration in the hemp-based CBD market and is currently working on securing a cultivation site for test crops. Neutra is positioned within the booming CBD market, promising growth for its shareholders.
Neutra Corporation (OTC PINK:NTRR) subsidiary VIVIS is enhancing its market presence with a new CBD pain cream and a nationwide sales team to support its launch. The cream features a 1000 mg broad spectrum CBD dosage, designed to alleviate chronic pain, which affects over 116 million Americans. Priced competitively with existing products, this offering aims to capture greater market share and generate additional revenue. CEO Sydney Jim emphasizes the cream's quality and potential popularity among both retailers and consumers, as it aligns with the growing demand for hemp-based solutions.
Neutra Corp. (OTC PINK:NTRR) has announced the finalization of its CBD-based gummy formula and packaging via its subsidiary, VIVIS Corp. The gummies, containing 50mg of Broad-Spectrum CBD each, are set to launch within 2-3 weeks and will be available in 10 and 30 packs. They will be sold in select stores across Texas, Oklahoma, Louisiana, and California, along with online purchases at viviscbd.com. This launch coincides with a reported rise in CBD product popularity, with over 64 million Americans having tried CBD products recently.
Neutra Corporation (OTC PINK:NTRR) subsidiary VIVIS has secured a leasing deal with an Oklahoma cannabis firm to provide production equipment and consulting for a testing lab. This agreement follows a letter of intent signed earlier in September 2020. Neutra's CEO, Sydney Jim, highlights the potential for increased revenue in the burgeoning cannabis market. VIVIS has expanded rapidly, launching two new facilities near Houston, and has seen a boost in CBD product demand despite COVID-19. Market research shows 40% of CBD consumers are increasing usage, enhancing the company's position.
